NeutriSci International Inc.
NRXCFOTCHealthcare
$0.00
+$0.00(+0.00%)
Market Cap$653980
P/E Ratio—
52W High$0.0013
52W Low$0.0013
NeutriSci International Inc. (NRXCF) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · NRXCF · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2022-12 | 2021-12 | 2020-12 | 2019-12 | 2018-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.46M | $0.08M | $0.07M | $0.10M | $0.08M |
| Cost of Revenue | $0.50M | $0.10M | $0.08M | $0.09M | $0.08M |
| Gross Profit | ($0.04M) | ($0.02M) | ($0.01M) | $0.00M | $0.00M |
| Gross Margin %(computed) | -9.48% | -25.40% | -7.87% | 3.04% | 4.73% |
| Operating Expenses | |||||
| R&D Expenses | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| G&A Expenses | $0.60M | $1.25M | $1.71M | $1.42M | $1.72M |
| Total Operating Expenses | $0.65M | $1.37M | $1.94M | $1.65M | $2.28M |
| Operating Income | ($0.69M) | ($1.50M) | ($1.94M) | ($1.65M) | ($2.26M) |
| Operating Margin %(computed) | -150.81% | — | — | — | — |
| Interest Income | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Interest Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Income Before Tax | ($0.77M) | ($1.57M) | ($1.95M) | ($1.61M) | ($2.38M) |
| Income Tax Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.02M |
| Net Income | ($0.77M) | ($1.57M) | ($1.95M) | ($1.61M) | ($2.38M) |
| Net Margin %(computed) | -168.37% | — | — | — | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.00 | $-0.01 | $-0.01 | $-0.01 | $-0.02 |
| Wtd Avg Shares | 166.15M | 158.59M | 143.38M | 116.02M | 101.66M |
| EBITDA | ($0.73M) | ($1.53M) | ($1.92M) | ($1.61M) | ($2.36M) |
| EBITDA Margin %(computed) | -160.23% | — | — | — | — |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · CAD · M
Explore more NeutriSci International Inc. data
About NeutriSci International Inc. (NRXCF) Income Statement
NeutriSci International Inc. (NRXCF) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2022, NRXCF reported revenue of $0.00B, gross profit of ($0.00B) (gross margin -9.48%), and net income of ($0.00B) — a net profit margin of -168.37%.
Frequently asked questions
NRXCF · 4 questionsNeutriSci International Inc. (NRXCF) reported revenue of $0.00B for 2022, up 465.9% year-over-year.
NRXCF revenueNRXCF salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09